期刊文献+

小剂量尼尔雌醇对绝经后妇女脂蛋白(a)和血脂的调脂疗效 被引量:3

Lipids regulaling effects of small dose nylestriol on lipoprotein(a) and lipids in postmenopausal woman
原文传递
导出
摘要 目的 :观察小剂量、长效尼尔雌醇对绝经后妇女脂蛋白 (a)〔 Lp(a)〕和血脂的影响。方法 :选择绝经 2年以上的妇女 54例 ,随机分为治疗组和对照组。治疗组每月服尼尔雌醇 1次 ,每次 2mg。结果 :治疗组 3个月后 HDL- C、apo- AI明显升高 ,LDL- C降低 ,Lp(a)治疗半年后开始下降 ,治疗 9个月后与对照组相比有显著性差异 ,1年后降低仍较显著 ,TC、TG无明显改变。对照组前后无明显改变。结论 :尼尔雌醇副作用轻 ,同时减轻绝经期妇女的更年期综合征症状。对高 Lp(a)、高LDL- C或者低 HDL- Objective:To evaluate the lipids regulating effects of small dose nylestriol on lipoprotein(a) 〔Lp(a)〕 and lipids in postmenipause women.Method:54 cases of women who had menopause for more than 2 years were enrolled and randomly divided into 2 groups.Only 40 of them reached end points of 1 year observation.Group A(21 cases) received oral nylestriol 2 mg once monthly.Group B (19 cases) received placebo as control.Result:HDL C、apo AI increased after 3 months and LDL C decreased.The Lp(a) began to decrease after half a year.There were remarkable differences between two groups after 9 months and differences still existed after a year.TC and TG didn't change greatly.Conclusion:Hormone replacement therapy can decreases Lp(a) and LDL C levels,while increase HDL C levels.This effect may be one of the mechanisms of the cardioprotective effects of estrogen.Nylestriol has mild side effects and relieve the syndrome of postmenopausal.So it can be used as the first single drug to prevent women with high Lp(a)、high LDL C or low HDL C level from coronary heart disease.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 1999年第3期122-124,共3页 Journal of Clinical Cardiology
关键词 脂蛋白(a) 血脂 尼尔雌醇 绝经后 调脂 Lipoprotein(a) Lipids Nylestriol Menopause
  • 相关文献

参考文献4

  • 1陆湘云,颜本元.尼尔雌醇治疗更年期综合征339例[J].新药与临床,1989,8(3):183-186. 被引量:36
  • 2束怀清.雌激素作用及其原理[J].国外医学妇产科分册,1979,6:159-165.
  • 3陆湘云,新药与临床,1989年,8卷,183页
  • 4束怀清,国外医学.妇产科分册,1979年,6卷,159页

共引文献35

同被引文献45

  • 1程国钧,刘建立.绝经后妇女口服尼尔雌醇的前瞻性研究[J].中华妇产科杂志,1993,28(9):534-538. 被引量:44
  • 2鲁翔,黎珉,吴斌,桂鸣,谢文桂,程蕴琳.绝经猕猴心脏老化及尼尔雌醇对其影响[J].中华老年医学杂志,1995,14(4):240-242. 被引量:5
  • 3谢文桂,古秋娥,颜松芬,黄秀娟,江世强,唐明,陈国庆,袁耀萼,冯华.尼尔雌醇对去卵巢猕猴实验性动脉粥样硬化的研究[J].广西医学,1995,17(6):491-494. 被引量:3
  • 4MacLennan A, Lester S, Moore, V. Oral oestrogen replacement therapy versus placebo for hot flushes [ DB/OL ]. Cochrane Library, Date of Most Recent Update: 20-November2002. Date of Most Recent Substantive Update: 19-September-2000
  • 5Lethaby A, Farquhar C, Sarkis A, Roberts H, Jepson R, Barlow D. Hormone replacement therapy in postmenopausal women: endomertial hyperplasia and irregular bleeding ( Cochrane Review) [ DB/OL ]. Cochrane Library, Date of Most Recent Update: 18-November-2002. Date of Most Recent Substantive Update: 24-February-1999
  • 6Norman RJ, Flight IHK, Rees MCP. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution ( Cochrane Review )[DB/OL]. Cochrane Library, Date of Most Recent Update: 20-November-2002. Date of Most Recent Substantive Update: 13-May-1999
  • 7Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV,Johnson .KC, Kotchen JM, Ockene J. Writing group for the Women's Health Initiative investigation. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial[J]. JAMA, 2002; 288 (3): 321 - 333
  • 8Al-Azzawi F, Wahab M, Habiba M, Akkad A, Mason T.Continuous combined hormone replacement therapy compared with tibolone [ J ]. Obstetrics & Gynecology, 1999; 93 (2):258 -264
  • 9Kokcu A, Cetinkaya MB, Yanik F, Alper T, Malatyalioglu E.Thecomparison of effects of tibolone and conjugated estrogen-medroxyprogesterone acetate therapy on sexual performance in postmenopausal women [ J]. Maturitas, 2000; 36 ( 1 ): 75-80
  • 10Baracat EC, Barbosa IC, Giordano MG, Haidar MA, Marinho RM, Menegocci JC, Morais KM, Tomaz G, Wehba S. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability[J]. Climacteric,2002; 5 ( 1 ): 60 - 69

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部